Quality of information and decision regret during fertility sparing management for atypical hyperplasia and endometrial cancer

被引：0
|
作者：
Haim, Noemie [1 ]
Vandenbroucke, Tineke [2 ]
Bourdet, Alice [1 ]
Amant, Frederic [2 ,3 ]
Koskas, Martin [1 ]
机构：
[1] Paris Diderot Univ, Bichat Univ Hosp, Paris, France
[2] Ku Leuven Univ Leuven, Univ Hosp Leuven, Leuven, Belgium
[3] Netherlands Canc Inst, Antoni van Leeuwenhoek, Amsterdam, Netherlands
来源：
PSYCHO-ONCOLOGY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
235
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [21] A practical guideline on the fertility-sparing treatment of patients with endometrial carcinoma and atypical endometrial hyperplasia
    Catena, Ursula
    Macklon, Kirsten Louise Tryde
    Rodolakis, Alexandros
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025,
  • [22] THE RISK FACTORS AND THERAPEUTIC REGIMENS ANALYSES IN THE FERTILITY-SPARING TREATMENT OF REFRACTORY ENDOMETRIAL ATYPICAL HYPERPLASIA AND ENDOMETRIAL CANCER
    Yang, B.
    Zhou, S.
    Chen, X.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A381 - A381
  • [23] Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin
    Simpson, Andrea N.
    Feigenberg, Tomer
    Clarke, Blaise A.
    Gien, Lilian T.
    Ismiil, Nadia
    Laframboise, Stephane
    Massey, Christine
    Ferguson, Sarah E.
    GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 229 - 233
  • [24] Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment
    Gonthier, Clementine
    Piel, Bruno
    Touboul, Cyril
    Walker, Francine
    Cortez, Annie
    Luton, Dominique
    Darai, Emile
    Koskas, Martin
    ANTICANCER RESEARCH, 2015, 35 (12) : 6799 - 6804
  • [25] METFORMIN MAY ATTENUATE THE EFFECT OF HYPERPROLACTINEMIA INDUCED BY MEDROXYPROGESTERONE ACETATE DURING FERTILITY-SPARING TREATMENT FOR PATIENTS WITH ATYPICAL ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER
    Mitsuhashi, A.
    Gu, W.
    Habu, U.
    Kobayashi, T.
    Shozu, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A346 - A346
  • [26] PROGNOSTIC FACTORS IN FERTILITY-SPARING MANAGEMENT OF ENDOMETRIAL ATYPICAL HYPERPLASIA AND ADENOCARCINOMA RESTRICTED TO ENDOMETRIUM: SYSTEMATIC REVIEW
    Gonthier, C.
    Popescu, N.
    Koskas, M.
    Luton, D.
    Uzan, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1273 - 1273
  • [27] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra G.
    Kahn, Jenna L.
    Shah, Divya K.
    Ko, Emily M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 393 - 394
  • [28] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra
    Kahn, Jenna
    Shah, Divya
    Ko, Emily
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S122 - S122
  • [29] Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer
    Mitsuhashi, A.
    Sato, Y.
    Kiyokawa, T.
    Koshizaka, M.
    Hanaoka, H.
    Shozu, M.
    ANNALS OF ONCOLOGY, 2016, 27 (02) : 262 - 266
  • [30] Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review
    Murakami, Isao
    Machida, Hiroko
    Morisada, Tohru
    Terao, Yasuhisa
    Tabata, Tsutomu
    Mikami, Mikio
    Hirashima, Yasuyuki
    Kobayashi, Yoichi
    Baba, Tsukasa
    Nagase, Satoru
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 34 (04)
12345